Immunohistochemical analysis of pancreatic tumor tissues also revealed that UA, alone or in combination with gemcitabine, significantly decreased the expression of cyclin D1, COX-2, VEGF, and MMP-9 molecules compared with the control treatment (Figure 6A). The gene discussed is PTGS2; the disease is pancreatic neoplasm.